110 related articles for article (PubMed ID: 1708670)
1. Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Evidence for vitronectin/PAI-2 complexes in human placenta extract.
Radtke KP; Wenz KH; Heimburger N
Biol Chem Hoppe Seyler; 1990 Dec; 371(12):1119-27. PubMed ID: 1708670
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
Declerck PJ; De Mol M; Alessi MC; Baudner S; Pâques EP; Preissner KT; Müller-Berghaus G; Collen D
J Biol Chem; 1988 Oct; 263(30):15454-61. PubMed ID: 2459123
[TBL] [Abstract][Full Text] [Related]
3. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
Wun TC; Palmier MO; Siegel NR; Smith CE
J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3.
Stief TW; Radtke KP; Heimburger N
Biol Chem Hoppe Seyler; 1987 Oct; 368(10):1427-33. PubMed ID: 3501295
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma.
Wiman B; Almquist A; Sigurdardottir O; Lindahl T
FEBS Lett; 1988 Dec; 242(1):125-8. PubMed ID: 2462509
[TBL] [Abstract][Full Text] [Related]
6. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
Wun TC; Reich E
J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1).
Alessi MC; Declerck PJ; De Mol M; Nelles L; Collen D
Eur J Biochem; 1988 Aug; 175(3):531-40. PubMed ID: 3261688
[TBL] [Abstract][Full Text] [Related]
8. Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasma.
Alessi MC; Juhan-Vague I; Declerck PJ; Collen D
Thromb Res; 1991 May; 62(4):275-85. PubMed ID: 1907771
[TBL] [Abstract][Full Text] [Related]
9. Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.
Lindahl T; Wiman B
Biochim Biophys Acta; 1989 Feb; 994(3):253-7. PubMed ID: 2493266
[TBL] [Abstract][Full Text] [Related]
10. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
11. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
Keijer J; Ehrlich HJ; Linders M; Preissner KT; Pannekoek H
J Biol Chem; 1991 Jun; 266(16):10700-7. PubMed ID: 1709939
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a plasma factor which cleaves single-chain form of t-PA and u-PA.
Okada K; Fukao H; Tanaka H; Ueshima S; Matsuo O
Thromb Res Suppl; 1990; 10():27-43. PubMed ID: 2156352
[TBL] [Abstract][Full Text] [Related]
13. Identity between the placental protein PP10 and the specific plasminogen activator inhibitor of placental type PAI-2.
Kiso U; Henschen A; Bohn H; Heimburger N; Radtke KP; Lecander I; Astedt B
Biochim Biophys Acta; 1991 May; 1074(1):74-8. PubMed ID: 2043683
[TBL] [Abstract][Full Text] [Related]
14. A molecular variant of plasminogen activator inhibitor of rat decidual tissue.
Tarachand U; Pawse AR
Biochem Mol Biol Int; 1995 Dec; 37(6):1037-45. PubMed ID: 8747533
[TBL] [Abstract][Full Text] [Related]
15. Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin.
Mimuro J; Loskutoff DJ
J Biol Chem; 1989 Jan; 264(2):936-9. PubMed ID: 2463252
[TBL] [Abstract][Full Text] [Related]
16. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
Ehrlich HJ; Gebbink RK; Preissner KT; Keijer J; Esmon NL; Mertens K; Pannekoek H
J Cell Biol; 1991 Dec; 115(6):1773-81. PubMed ID: 1721912
[TBL] [Abstract][Full Text] [Related]
17. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
Takeuchi T; Niiya K; Kubonishi I; Miyoshi I
Thromb Haemost; 1990 Apr; 63(2):259-64. PubMed ID: 2363126
[TBL] [Abstract][Full Text] [Related]
18. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
Thorsen S; Philips M
Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
[TBL] [Abstract][Full Text] [Related]
19. Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.
Wagner OF; Vetterlein M; Binder BR
J Biol Chem; 1986 Nov; 261(31):14474-81. PubMed ID: 3490474
[TBL] [Abstract][Full Text] [Related]
20. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin.
Salonen EM; Vaheri A; Pöllänen J; Stephens R; Andreasen P; Mayer M; Danø K; Gailit J; Ruoslahti E
J Biol Chem; 1989 Apr; 264(11):6339-43. PubMed ID: 2467912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
